In December 2019 Dr. Cuttino was promoted to a Senior AME for the FAA. He now offers Class 1, 2, and 3 exams.
The Richmond Times Dispatch interviewed me and discussed the development of Orbital Medicine. You can read the article on the AP Press Link Here.
Coming soon Orbital Medicine has begun a new service to connect flight providers, researchers, educators, and material providers.
The service is designed as a market place to share lessons learned, find new partners, and expand the capabilities of the new space age.
Come and find your launch mate!
Dr. Cuttino will be speaking and presenting at the Next Generation Suborbital Researchers Conference March 2-4 in Boulder, CO.
He will be presenting and speaking on Human Tended Research and spaceflight, dealing with panic during spaceflight, and mentoring students.
See the NSRC 2020 website for more details.
Orbital Medicine achieves successful test flight with specialized medical device for collapsed lungs in space
Suction device could save lives in space and would be required for Moon, Mars missions
RICHMOND, VA (DECEMBER 12, 2017) – Private aerospace company Blue Origin launched its New Shepard space vehicle on Dec 12 with a payload that included a medical device to treat traumatic chest trauma in a zero-gravity space environment.
The Evolved Medical Microgravity Suction Device, developed by C. Marsh Cuttino, MD and his team at Orbital Medicine Inc. in Richmond, could assist in treatment of a collapsed lung where air and blood enter the pleural cavity. The payload – which included the device along with a hemothorax simulator – was constructed in collaboration with the Purdue University School of Aeronautics and Astronautics.
In the event an astronaut suffers from a collapsed lung (traumatic pneumothorax) in space, they must return to Earth quickly for medical treatment with gravity-dependent collectors that will not work in a zero-gravity environment. The Orbital Medicine Evolved Medical Microgravity Suction Device, however, is able to collect blood in microgravity, and still allows for the suction to continuously inflate the lung and allow it to heal. The device is constructed so blood can be collected and transfused into an injured astronaut.
The payload test apparatus has a microgravity suction system, collection device, and pneumothorax simulator. The apparatus simulates an injured person, and shows how the device removes the air and blood to promote healing.
“My hope is that in the future, this type of medical device will be able to save the life of an astronaut, to continue their mission of exploration,” Dr. Cuttino said. “These types of medical treatment options will be required to explore the Moon and Mars.”
The Orbital Medicine payload flew onboard Blue Origin’s New Shepard system, a space vehicle capable of vertical takeoffs and landings and able to carry hundreds of pounds of payloads per flight. New Shepard is expected to ultimately carry six astronauts to altitudes beyond 100 kilometers, the internationally-recognized boundary of space.
Orbital Medicine’s suction device technology was selected in November 2015 under a NASA Flight Opportunities Grant, and has already flown on parabolic flights with program funding. Previous parabolic flights helped to refine the design, and paved the way for the current private test with Blue Origin.
ABOUT ORBITAL MEDICINE
Orbital Medicine Inc. was founded by Charles Marsh Cuttino, MD to develop and provide healthcare solutions for the space environment. Dr. Cuttino is a board-certified emergency physician who is experienced in aerospace medicine, disaster, and mass casualty medicine. A former professor, he is currently the Chairman of Emergency Medicine for a five-hospital system and a Federal Aviation Administration Aviation Medical Examiner. He has provided past medical support for NASA Space Shuttle operations, and continues to research microgravity medical issues. For more information, visit www.orbitalmedicine.com.
Dr. Cuttino will be speaking on his event medical experiences in a talk entitled:
“NASCAR to NASA: Event Medicine for Suborbital Spaceflight Operations”
The talk will highlight the challenges and opportunities when providing medical support in complex environments with significant technical challenges. The link to the abstract is provided here.
Dr. Cuttino is a member of the NSRC program committee, and will be chairing 2 panel sessions.
Monday, December 18th, 2017
4:00pm – 5:00pm
“Human Tended Research Flights”
Chair: Marsh Cuttino
Panelists: Sirisha Bandla; Dan Durda; Michelle Peters; Erika Wagner; Charlie Walker
Tuesday December 19th, 2017
4:00pm – 5:00pm
“Spacecraft Risk and Safety Concerns”
Chair: Marsh Cuttino, M.D.
Panelists: Jeff Ashby; Melchor Antuñano, M.D., M.S.; Jim Vanderplough, M.D.
The parabolic flight testing performed by Orbital Medicine in November 2016 was highlighted in the June 2017 newsletter of NASA Flight Opportunities.
You can read it on the link here.
The June edition of Smithsonian Magazine featured an article by Charles Fishman, titled “The Future of Zero-Gravity Living is Here”. The story includes some of the parabolic flight research performed by Orbital Medicine, and includes photos taken during the parabolic flight campaign. The article can be read here.
Dr. Cuttino of Orbital Medicine, Inc is in Seattle for ACEP 2013.
A highlight of the convention is the reception sponsored by EmCare at the Seattle Museum of Flight.